Pharmaceutical research and development returns are improving despite rising costs and increasing competition. The industry is seeing advancements in areas such as bioprocessing and drug discovery, with some companies forming partnerships and receiving investments to drive innovation. However, the sector also faces challenges, including potential price cuts and intense competition, which may impact the viability of some pharmaceutical ecosystems.